A Chromatographic method for the production of a human immunoglobulin G solution for intravenous use

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 11, 1998, Pages 1375-1381

  Tanaka, K ^a   Sawatani, E ^a   Shigueoka, E M ^a   Campos, T C X B ^a   Nakao, H C ^a   Dias, G A ^a   Fujita, R K ^a   Arashiro, F ^a  

^a FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

Author keywords

Downstream process; Hemoderivate production; Immunoglobulin G production; Industrial chromatography; Intravenous gamma globulin production

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ARTICLE; CHEMISTRY; CHROMATOGRAPHY; HUMAN;

CHROMATOGRAPHY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 0032199466     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998001100002     Document Type: Article

References (20)

1. Pharmacopée Européenne (1997). 2nd edn. Part II Maisonneuve SA., Sainte Ruffine.
2. Cohn EJ, Strong LE, Hughes Jr WL, Mulford DJ, Ashworth JN, Melin M & Taylor HL (1946). Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. Journal of the American Chemical Society, 68: 459-475.
3. Mielka SI & Gozze I (1975). Anticomplementary activity of human immunoglobulin G. I. Mechanism of the artifactual increase in anticomplementary activity of IgG during the assay. Vox Sanguinis, 29: 101-123.
4. Andersson I, Lindquist LO & Berglöf J (1994). An improved chromatography method for production of IgG from plasma. XXIII Congress of the International Society of Blood Transfusion, The Netherlands, July 2-8.
5. Curling JM (1983). Separation of Plasma Proteins. Pharmacia Fine Chemicals AB, Uppsala.
6. Cohn EJ, Gurd FRN, Surgenor DM, Barnes BA, Brown RK, Deronaux G, Gillespie JM, Kahnt FW, Lever WF, Liu CH, Mittelman D, Mouton RF, Schmid K & Uroma E (1950). A system for the preparation of the components of human blood: quantitative procedures for the separation of the protein components of human plasma. Journal of the American Chemical Society, 72: 465-474.
7. Oncley M, Melin DA, Richert JW, Cameron JW & Cross Jr PM (1949). The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and ß1-lipoprotein into subfractions of human plasma. Journal of the American Chemical Society, 71: 541-550.
8. Barandun S, Kistler P, Jeunet F & Isliker H (1962). Intravenous administration of human γ-globulin. Vox Sanguinis, 7: 157-174.
9. Hässig A (1986). Intravenous immunoglobulins: pharmacological aspects and therapeutic use. Vox Sanguinis, 51: 10-17.
10. Schultze HE & Schwick G (1962). Über neue Möglichkeiten intravenöser Gamma-globulin-Applikation. Deutsche Medizinische Wochenschrift, 87: 1643-1650.
11. Sgouris JT (1967). The preparation of plasmin treated immune serum globulin for intravenous use. Vox Sanguinis, 13: 71-84.
12. Fernandes PM & Lundblad JL (1980). Preparation of a stable intravenous gamma-globulin: process design and scale-up. Vox Sanguinis, 39: 101-112.
13. Stephan W (1975). Undergraded human immunoglobulin for intravenous use Vox Sanguinis, 28: 422-437.
14. Pappenhagen A, Lundblad J & Schroeder D (1975). Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use. US Patent No. 3,903,262.
15. Schmidtberger R (1978). Arridated immune globulins and process for preparing them. US Patent No. 4,118,379.
16. Masuho Y, Tomibes S, Matsuzawa K & Ohtdu A (1977). Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin. Vox Sanguins, 32: 175-181.
17. WHO Expert Committee on Biological Standardization (1982). Report of an informal meeting on intravenous immunoglobulins (human), Geneva.
18. Tanaka K, Sawatani E, Nakao HC, Dias GA & Arashiro F (1996). An alternative column Chromatographic process for the production of human albumin. Brazilian Journal of Medical and Biological Research, 29: 185-191.
19. Horowitz B, Wieb ME, Lippin A & Stryker H (1985). Inactivation of viruses in labile blood derivatives. Transfusion, 25: 516-522.
20. McCue JP, Hein RH & Tendold R (1986). Three generations of immunoglobulin G preparations for clinical use. Reviews of Infectious Diseases, 8 (Suppl 4): 374-381.